505 related articles for article (PubMed ID: 27147945)
1. Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.
Miliano C; Serpelloni G; Rimondo C; Mereu M; Marti M; De Luca MA
Front Neurosci; 2016; 10():153. PubMed ID: 27147945
[TBL] [Abstract][Full Text] [Related]
2. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
Zawilska JB; Andrzejczak D
Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
[TBL] [Abstract][Full Text] [Related]
3. Sex and Gender Differences in the Effects of Novel Psychoactive Substances.
Fattore L; Marti M; Mostallino R; Castelli MP
Brain Sci; 2020 Sep; 10(9):. PubMed ID: 32899299
[TBL] [Abstract][Full Text] [Related]
4. "Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.
Zawilska JB
Int Rev Neurobiol; 2015; 120():273-300. PubMed ID: 26070762
[TBL] [Abstract][Full Text] [Related]
5. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
Liechti M
Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
[TBL] [Abstract][Full Text] [Related]
6. Novel Psychoactive Substances: The Razor's Edge between Therapeutical Potential and Psychoactive Recreational Misuse.
Correia B; Fernandes J; Botica MJ; Ferreira C; Quintas A
Medicines (Basel); 2022 Mar; 9(3):. PubMed ID: 35323718
[TBL] [Abstract][Full Text] [Related]
7. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
Palamar JJ; Martins SS; Su MK; Ompad DC
Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
[TBL] [Abstract][Full Text] [Related]
8. NPS: Medical Consequences Associated with Their Intake.
Schifano F; Orsolini L; Papanti D; Corkery J
Curr Top Behav Neurosci; 2017; 32():351-380. PubMed ID: 27272067
[TBL] [Abstract][Full Text] [Related]
9. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
[No Abstract] [Full Text] [Related]
10. Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?
Hondebrink L; Zwartsen A; Westerink RHS
Pharmacol Ther; 2018 Feb; 182():193-224. PubMed ID: 29097307
[TBL] [Abstract][Full Text] [Related]
11. Synthetic drugs of abuse.
Tamama K
Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
[TBL] [Abstract][Full Text] [Related]
12. Analysis of new classes of recreational drugs in sewage: synthetic cannabinoids and amphetamine-like substances.
Reid MJ; Derry L; Thomas KV
Drug Test Anal; 2014; 6(1-2):72-9. PubMed ID: 23460377
[TBL] [Abstract][Full Text] [Related]
13. Synthetic cathinones: an evolving class of new psychoactive substances.
Gonçalves JL; Alves VL; Aguiar J; Teixeira HM; Câmara JS
Crit Rev Toxicol; 2019 Aug; 49(7):549-566. PubMed ID: 31747318
[TBL] [Abstract][Full Text] [Related]
14. Emerging drugs in Europe.
Papaseit E; Farré M; Schifano F; Torrens M
Curr Opin Psychiatry; 2014 Jul; 27(4):243-50. PubMed ID: 24840157
[TBL] [Abstract][Full Text] [Related]
15. New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?
Giné CV; Espinosa IF; Vilamala MV
Drug Test Anal; 2014; 6(7-8):819-24. PubMed ID: 24470121
[TBL] [Abstract][Full Text] [Related]
16. New psychoactive substance use among regular psychostimulant users in Australia, 2010-2015.
Sutherland R; Peacock A; Whittaker E; Roxburgh A; Lenton S; Matthews A; Butler K; Nelson M; Burns L; Bruno R
Drug Alcohol Depend; 2016 Apr; 161():110-8. PubMed ID: 26880592
[TBL] [Abstract][Full Text] [Related]
17. Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopaminergic pathways, glial cells alterations, and behavioural correlates.
Pintori N; Castelli MP; Miliano C; Simola N; Fadda P; Fattore L; Scherma M; Ennas MG; Mostallino R; Flore G; De Felice M; Sagheddu C; Pistis M; Di Chiara G; De Luca MA
Br J Pharmacol; 2021 Sep; 178(17):3476-3497. PubMed ID: 33837969
[TBL] [Abstract][Full Text] [Related]
18. Novel psychoactive substances of interest for psychiatry.
Schifano F; Orsolini L; Duccio Papanti G; Corkery JM
World Psychiatry; 2015 Feb; 14(1):15-26. PubMed ID: 25655145
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.
Simmler LD; Liechti ME
Handb Exp Pharmacol; 2018; 252():143-164. PubMed ID: 29633178
[TBL] [Abstract][Full Text] [Related]
20. A narrative review of the neuropharmacology of synthetic cathinones-Popular alternatives to classical drugs of abuse.
Kuropka P; Zawadzki M; Szpot P
Hum Psychopharmacol; 2023 May; 38(3):e2866. PubMed ID: 36866677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
